TrialJournal of the Pediatric Infectious Diseases Society2016

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial.

Long Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.